| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044935 Peptides of IL-2 and derivatives thereof and their use as therapeutic agents |
| 04/18/2002 | US20020044928 Immunization of dairy cattle with chimeric GapC protein against streptococcus infection |
| 04/18/2002 | US20020044923 Modulating immune responses using antigen presenting human mesenchymal stem cells to induce specific T cell anergy |
| 04/18/2002 | US20020044922 Recombinant phages |
| 04/18/2002 | DE10136984A1 Für das sigM-Gen kodierende Nukleotidsequenzen For the Sigm gene coding nucleotide sequences |
| 04/18/2002 | DE10113958A1 Neue für das mikE17-Gen kodierende Nukleotidsequenzen New coding for the mikE17 gene nucleotide sequences |
| 04/18/2002 | DE10050070A1 New antiproliferative peptides and nucleic acids useful especially for diagnosis and treatment of tumors, atherosclerosis and psoriasis |
| 04/18/2002 | DE10044384A1 Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung Host cells for the packaging of recombinant adeno-associated virus (rAAV), processes for their preparation and their use |
| 04/18/2002 | CA2426753A1 Mammalian wnt polypeptide-5 |
| 04/18/2002 | CA2425917A1 Artificial transcriptional factors and methods of use |
| 04/18/2002 | CA2425885A1 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains |
| 04/18/2002 | CA2425833A1 Egf motif protein, egfl6 materials and methods |
| 04/18/2002 | CA2425827A1 Novel nucleic acids and polypeptides |
| 04/18/2002 | CA2425818A1 Novel human beta2 integrin alpha subunit |
| 04/18/2002 | CA2425779A1 Compositions that inhibit proliferation of cancer cells |
| 04/18/2002 | CA2425767A1 Lipocalins |
| 04/18/2002 | CA2425671A1 Human ect2 and methods of use |
| 04/18/2002 | CA2425643A1 Cancer-linked genes as targets for chemotherapy |
| 04/18/2002 | CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | CA2425515A1 Human ion channel protein and polynucleotides encoding the same |
| 04/18/2002 | CA2425486A1 Flea peritrophin nucleic acid molecules, proteins and uses thereof |
| 04/18/2002 | CA2425318A1 Far red shifted fluorescent proteins |
| 04/18/2002 | CA2425302A1 Novel polypeptides homologous to thymosin, ephrin a, receptors, and fibromodulin, and polynucleotides encoding same |
| 04/18/2002 | CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | CA2425293A1 A novel system for the evaluation of the activity and/or specificity of a viral component |
| 04/18/2002 | CA2425194A1 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal |
| 04/18/2002 | CA2424992A1 Paramyxovirus vectors for introducing foreign genes into skeletal muscle |
| 04/18/2002 | CA2424987A1 Methods of agonizing and antagonizing fabk |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424946A1 Non typeable haemophilus influenzae basb201 polypeptides and encoding polynucleotides and uses thereof |
| 04/18/2002 | CA2424938A1 Basb205 polypeptides and polynucleotides encoding therefor |
| 04/18/2002 | CA2424933A1 Haemophilus influenza basb203 polypeptides and encoding polynucleotides and uses thereof |
| 04/18/2002 | CA2424821A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | CA2424433A1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | CA2424295A1 Metal binding proteins, recombinant host cells and methods |
| 04/18/2002 | CA2393680A1 A schizophrenic model animal with sensorimotor and behavioral abnormalities and a method for preparing the same |
| 04/17/2002 | EP1197554A1 Proliferation differentiation factor |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197495A2 DNA-binding protein YB-1-containing collagen accumulation inhibitors |
| 04/17/2002 | EP1197222A2 A stabilized pharmaceutical formulation comprising growth hormone and histidine |
| 04/17/2002 | EP1197220A2 Therapeutic methods and compositions based on delta proteins and nucleic acids |
| 04/17/2002 | EP1197154A1 Vegetable protein composition containing an isoflavone-depleted vegetable protein material with an isoflavone-containing material |
| 04/17/2002 | EP1197144A1 Transgenic mice and overexpression model of the gene ntrk3 (trkc) based thereon for the study and monitoring of treatments of anxiety, depression and related psychiatric diseases |
| 04/17/2002 | EP1197032A2 Server-assisted regeneration of a strong secret from a weak secret |
| 04/17/2002 | EP1196782A1 Catalytic anti-factor viii allo-antibodies |
| 04/17/2002 | EP1196779A1 Determining antibodies to ny-eso-1 in cancer patients |
| 04/17/2002 | EP1196772A2 Induction of a th1-like response in vitro |
| 04/17/2002 | EP1196638A1 USE OF THE i KRIT1 /i GENE IN ANGIOGENESIS |
| 04/17/2002 | EP1196637A1 Peptide acceptor ligation methods |
| 04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
| 04/17/2002 | EP1196616A2 Replication-competent anti-cancer vectors |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196607A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 04/17/2002 | EP1196602A1 Dihydroorotate dehydrogenase sequence of corynebacterium glutamicum and the use thereof in microbial production of pyrimidine and/or compounds used with pyrimidine |
| 04/17/2002 | EP1196601A1 Compositions and methods for fumonisin detoxification |
| 04/17/2002 | EP1196596A1 Mosaic infectious bursal disease virus vaccines |
| 04/17/2002 | EP1196595A2 Methods of inducing cell death |
| 04/17/2002 | EP1196594A2 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 04/17/2002 | EP1196593A2 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 04/17/2002 | EP1196591A1 Moraxella catarrhalis polypeptides |
| 04/17/2002 | EP1196589A1 Cloning of basb110 antigen from moraxella (branhamella) catarrhalis |
| 04/17/2002 | EP1196588A1 Basb113 polypeptide antigen from moraxella catarrhalis |
| 04/17/2002 | EP1196587A2 Antigenic meningococcal peptides |
| 04/17/2002 | EP1196586A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 04/17/2002 | EP1196585A1 Insecticidal proteins from paecilomyces and synergistic combinations thereof |
| 04/17/2002 | EP1196584A1 Tetanus toxin polypeptides |
| 04/17/2002 | EP1196583A2 GENOME SEQUENCE AND POLYPEPTIDES OF PYROCOCCUS $i(ABISSY), FRAGMENT AND USES THEREOF |
| 04/17/2002 | EP1196582A1 Genetic control of flowering using the fwa gene |
| 04/17/2002 | EP1196581A1 Promoter expressed specifically in the cells of plant roots, recombinant vectors and host cells comprising same and transgenic plants obtained |
| 04/17/2002 | EP1196580A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF |
| 04/17/2002 | EP1196579A2 Tryptase inhibitor |
| 04/17/2002 | EP1196578A1 Axor39, a g-protein coupled receptor with 7-tm segments |
| 04/17/2002 | EP1196577A2 Cell cycle and proliferation proteins |
| 04/17/2002 | EP1196576A2 Secreted polypeptides and corresponding polynucleotides |
| 04/17/2002 | EP1196575A2 Gtp-binding protein associated factors |
| 04/17/2002 | EP1196574A2 Human proteins involved in detoxification |
| 04/17/2002 | EP1196573A1 A human lactoferrin produced by using an insect cell and method using the same |
| 04/17/2002 | EP1196572A1 Axor21, a g-protein coupled receptor |
| 04/17/2002 | EP1196571A1 Orbit and homologues thereof |
| 04/17/2002 | EP1196570A2 Human polypeptides and methods for the use thereof |
| 04/17/2002 | EP1196569A2 Electron transfer proteins |
| 04/17/2002 | EP1196568A1 Human lim domain proteins |
| 04/17/2002 | EP1196567A2 Human immune response molecules |
| 04/17/2002 | EP1196566A1 Expression vectors and methods |
| 04/17/2002 | EP1196565A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 04/17/2002 | EP1196564A2 Atherosclerosis-associated genes |
| 04/17/2002 | EP1196563A2 Novel molecules of the card-related protein family and uses thereof |
| 04/17/2002 | EP1196562A1 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 04/17/2002 | EP1196561A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/17/2002 | EP1196560A1 Neurotrophic factor receptor gfr-alpha-4 |
| 04/17/2002 | EP1196557A1 Method of correlating sequence function by transfecting a nucleic acid sequence of a donor organism into a plant host in an anti-sense or positive sense orientation |
| 04/17/2002 | EP1196553A1 Arabidopsis thaliana cyclic nucleotide-gated ion channel dnd genes; regulators of plant disease resistance and cell death |
| 04/17/2002 | EP1196544A2 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 04/17/2002 | EP1196543A2 Treatment of dendritic cells for induction of immune tolerance |
| 04/17/2002 | EP1196450A1 Fibrin citrulline derivatives and their use for diagnosing or treating rheumatoid arthritis |
| 04/17/2002 | EP1196449A1 A method of modulating integrin mediated cellular activity and agents useful for same |
| 04/17/2002 | EP1196448A2 Homomeric and heteromeric ampa receptors |
| 04/17/2002 | EP1196447A1 Method for stabilising proteins in complex mixtures during their storage in aqueous solvents |